SCHEMBL22686756

SCHEMBL22686756

C#Cc1cc2c(cc1C=O)OCO2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
HPGD P15428 1/20 0.50
ALDH1A1 P00352 6/20 0.43
TDP1 Q9NUW8 2/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 4/20 0.38
KMT2A Q03164 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ERN1 O75460 1/20 0.35
MAPK1 P28482 2/20 0.34
MITF O75030 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HTT P42858 1/20 0.33
MEN1 O00255 2/20 0.32
IGF1R P08069 1/20 0.32
SRD5A2 P31213 1/20 0.31
KDM4E B2RXH2 2/20 0.31
CYP3A4 P08684 2/20 0.31
ATM Q13315 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL584339 0.81 HPGD (0.50) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL14070022 0.80 LMNA (0.64) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL30657003 0.76 LMNA (0.49) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL915300 0.76 LMNA (0.49) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL21593782 0.74 LMNA (0.43) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL30657001 0.73 LMNA (0.69) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL29198713 0.73 LMNA (0.69) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL4594814 0.71 LMNA (0.59) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL22133239 0.71 LMNA (0.55) LMNAHPGDALDH1A1TDP1HSD17B10
SCHEMBL2890802 0.71 HPGD (0.59) LMNAHPGDALDH1A1TDP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117069732-B Preparation method of benzo [ c ] phenanthridine natural product and derivative thereof 沈阳药科大学 2024-04-26 CN disclosed
CN-117069732-A Preparation method of benzo [ c ] phenanthridine natural product and derivative thereof 沈阳药科大学 2023-11-17 CN disclosed
US-10913770-B2 Mertansine polypeptide conjugates VISION GLOBAL HOLDINGS LIMITED (CN) 2021-02-09 US disclosed
US-20200361988-A1 MERTANSINE POLYPEPTIDE CONJUGATES VISION GLOBAL HOLDINGS LIMITED (HK) 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361988-A1 MERTANSINE POLYPEPTIDE CONJUGATES NGLY1, ANPEP, VIP LMNA 2136/4885HPGD 3614/4885ALDH1A1 3769/4885
US-10913770-B2 Mertansine polypeptide conjugates NGLY1, ANPEP, VIP LMNA 2136/4885HPGD 3614/4885ALDH1A1 3769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.